<?xml version="1.0" encoding="UTF-8"?>
<p id="par0020">In addition to this direct antiviral action, its immunomodulatory effect, which justifies its use in the chronic treatment of rheumatoid arthritis and systemic lupus erythematosus, may be of special interest in SARS-CoV2 infection, especially in patients who develop a macrophage activation syndrome, extremely serious due to its common progression to multiple organ failure,
 <xref rid="bib0140" ref-type="bibr">5</xref>, 
 <xref rid="bib0145" ref-type="bibr">6</xref> and that until now has been treated with glucocorticoids and tocilizumab.
 <xref rid="bib0140" ref-type="bibr">
  <sup>5</sup>
 </xref> Given the fact that a circular letter recently published in the 
 <italic>Lancet</italic> pointed out that these drugs should be used with caution because they could prolong the infection time by depressing the immune system,
 <xref rid="bib0140" ref-type="bibr">5</xref>, 
 <xref rid="bib0150" ref-type="bibr">7</xref> the combined antiviral and immunomodulatory action of hydroxychloroquine makes its use pathophysiologically attractive.
</p>
